Related Experiment Video
Updated: Jan 12, 2026
04:49
Author Spotlight: Investigating the Mechanisms and Inducing Models of Polycystic Ovary Syndrome
Published on: July 5, 2024
1.7K
Integrative bioinformatics and transcriptomic analysis identifies biomarkers in Polycystic Ovary Syndrome through
Harshini Senthilkumar1, Mohanapriya Arumugam1
1Department of Biotechnology, School of Biosciences and Technology, Vellore Institute of Technology University, Vellore, Tamil Nadu 632014, India.
The Journal of Steroid Biochemistry and Molecular Biology
|November 5, 2025
Summary
This study identified novel gene biomarkers for Polycystic Ovary Syndrome (PCOS) by analyzing gene expression. These findings offer new molecular insights and potential therapeutic targets for PCOS management.
Area of Science:
- Endocrinology
- Genomics
- Molecular Biology
Background:
- Polycystic Ovary Syndrome (PCOS) is a prevalent endocrine disorder affecting women of reproductive age.
- Understanding the molecular mechanisms underlying PCOS is crucial for developing effective treatments.
Purpose of the Study:
- To identify differentially expressed genes (DEGs) in PCOS using high-throughput sequencing.
- To explore the biological pathways and regulatory networks involved in PCOS pathogenesis.
- To discover novel gene biomarkers for PCOS diagnosis and management.
Main Methods:
- High-throughput sequencing of PCOS and control samples.
- Bioinformatic analysis including gene expression profiling (DESeq2), Gene Ontology (GO) analysis, pathway analysis, and protein-protein interaction (PPI) network construction (STRING, Cytoscape).
- Identification of hub genes, regulatory miRNAs, transcription factors, and biomarker validation using LASSO regression and ROC analysis.
Main Results:
- 1267 differentially expressed genes (DEGs) were identified across two datasets.
- DEGs were enriched in immune response, cell activation, and response to external stimuli.
- Key pathways implicated include chemokine signaling and cytokine-cytokine receptor interaction.
- Hub genes (e.g., IL1B, PTPRC, ITGB2) and novel biomarkers (CCR7, FCGR3A, FCGR3B, ITGB2) were identified.
- Regulatory networks involving miRNAs and transcription factors were elucidated.
Conclusions:
- This study provides a comprehensive molecular understanding of PCOS pathogenesis.
- Identified DEGs, pathways, and regulatory networks offer potential therapeutic targets.
- Novel biomarkers like CCR7, FCGR3A, FCGR3B, and ITGB2 show significant promise for PCOS management.
